Keyphrases
6-mercaptopurine (6-MP)
50%
Caregiver Stress
25%
Childhood Acute Lymphoblastic Leukemia
50%
Clinical Cohort
25%
Clinical Symptoms
25%
Composite Likelihood
25%
Confidence Interval
36%
Copula Model
33%
Direct Agglutination Test
30%
Embryonic Gonad
37%
Epidemiology
25%
Escitalopram
50%
Familial Risk
25%
Fetal Gonad
25%
Fixed-dose Combination
25%
FSH Receptor
25%
Germ Cells
25%
Healthy Males
25%
High Transmission
25%
High-dose Methotrexate (HD-MTX)
25%
Hoarding
41%
Home-based
25%
Human Fetus
25%
Human Granulosa Cells
25%
India
75%
Long-lasting Insecticidal Nets
28%
Maintenance Therapy
25%
National Cohort Study
50%
Nepal
25%
Obesity
25%
Obsessive-compulsive Disorder
50%
Pediatric Hematology
25%
Placebo
35%
Pregnancy Trimester
25%
Primary Palliative Care
25%
Psychological Intervention
25%
Randomized Placebo-controlled Trial
32%
Register-based
33%
Risk of Miscarriage
25%
Sand Fly
25%
Sibship
25%
Small Antral Follicles
25%
Social Anxiety Disorder
50%
Symptom Dimensions
50%
Trimethoprim-sulfamethoxazole (TMP-SMX)
25%
Two-stage Estimation
50%
Venous Thromboembolism
25%
Visceral Leishmaniasis
45%
Vitamin D
25%
Vitamin D3
25%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Adrenal Insufficiency
25%
Bereavement
20%
Cigarette Smoking
25%
Cluster Randomized Trial
25%
Cohort Analysis
25%
Cohort Effect
25%
Cross Sectional Study
25%
Diabetes
25%
Direct Agglutination Test
16%
Drug Megadose
29%
Event Free Survival
27%
First Trimester Pregnancy
25%
Germ Cell
25%
Gonad
20%
Household
16%
Hydrocortisone
20%
Infection
37%
Leishmaniasis
50%
Leukemia
29%
Maintenance Therapy
25%
Mercaptopurine
50%
Methotrexate
50%
Pediatric Hematology
25%
Pediatric Oncology
25%
Pneumocystis Pneumonia
25%
Prevalence
39%
Randomized Controlled Trial
33%
Somatic Cell
25%
Symptomatic Treatment
25%
Trimethoprim/Sulfamethoxazole
25%
Venous Thromboembolism
25%
Visceral Leishmaniasis
50%
